William P Forbes

CIK 1314760 · EVP, Chief Development Officer · last filed 2026-06-08

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$94.2K

Companies

4

Total Filings

72

Lifetime Open-Market Net

-$16.39M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
HRTX EVP, Chief Development Officer 221,611 $0.40 $88.7K $74.2K 22 2026-06-08
XAIR Director 14,855 $0.37 $5.5K $90.7K 10 2025-11-06
TRVI Chief Development Officer $14.21 $0 4 2022-07-01
SALIX PHARMACEUTICALS LTD (SLXP) Delisted President, Medical R&D and CDO 51,714 -$16.55M 35 2015-03-11

Recent Filings · Page 3 of 8

72 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-06-07 HRTX Exer (M) +12,500 $0 EDGAR
2024-04-19 HRTX Exer (M) +3,874 $0 EDGAR
2024-03-21 XAIR Grant (A) $0 EDGAR
2024-01-19 HRTX Grant (A) $0 EDGAR
2023-11-21 HRTX Buy (P) +25,000 $27.3K EDGAR
2023-11-20 HRTX Buy (P) +50,000 $47.0K EDGAR
2023-04-03 XAIR Buy (P) +5,000 $33.4K EDGAR
2023-03-31 XAIR Grant (A) $0 EDGAR
2023-03-20 XAIR Buy (P) +5,000 $32.3K EDGAR
2022-07-01 TRVI Grant (A) $0 EDGAR
Showing 2130 of 72
Page 3 of 8
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.